Clinical Trials

임상시험 트래커

국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.

7,310 trials30 companiesClinicalTrials.gov ↗

Photo Jan Folwarczny / Unsplash

22 results

3상모집 중단 (진행 중)· Diphtheria-Tetanus-acellular Pertussis Vaccines
일본 건강한 임산부에서 디프테리아·파상풍·무세포 백일해(dTpa) 복합백신의 면역반응 및 안전성 연구
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
리드: GSK
상세 →NCT07596199
3상모집 중단 (진행 중)· Respiratory Syncytial Virus Infections
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
리드: GSK
상세 →NCT07220109
3상모집 중단 (진행 중)· Respiratory Syncytial Virus Infections
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
리드: GSK
상세 →NCT06534892
3상모집 중단 (진행 중)· Glioblastoma
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
협력: GSK
상세 →NCT06388733
3상모집 중단 (진행 중)· Lung Cancer, Non-Small Cell
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
리드: GSK
상세 →NCT06472076
3상모집 중단 (진행 중)· HIV Infections
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
협력: GSK
상세 →NCT06134362
3상모집 중단 (진행 중)· Herpes Zoster
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
리드: GSK
상세 →NCT05371080
3상모집 중단 (진행 중)· Asthma
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
협력: GSK
상세 →NCT04651777
3상모집 중단 (진행 중)· Eosinophilic Granulomatosis With Polyangiitis
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
리드: GSK
상세 →NCT05263934
3상모집 중단 (진행 중)· Endometrial Cancer
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
협력: GSK
상세 →NCT05201547
3상모집 중단 (진행 중)· Multiple Myeloma
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
리드: GSK
상세 →NCT06956170
3상모집 중단 (진행 중)· Multiple Myeloma
Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
리드: GSK
상세 →NCT06868667
3상모집 중단 (진행 중)· Multiple Myeloma
China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
리드: GSK
상세 →NCT06868654
3상모집 중단 (진행 중)· Neoplasms, Breast
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease
리드: GSK
상세 →NCT04915755
3상모집 중단 (진행 중)· Respiratory Syncytial Virus Infections
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
리드: GSK
상세 →NCT04732871
3상모집 중단 (진행 중)· Multiple Myeloma
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
리드: GSK
상세 →NCT04484623
3상모집 중단 (진행 중)· Cholestasis
Linerixibat Long-term Safety, and Tolerability Study
리드: GSK
상세 →NCT04167358
3상모집 중단 (진행 중)· Multiple Myeloma
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
리드: GSK
상세 →NCT04246047
3상모집 중단 (진행 중)· Multiple Myeloma
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
리드: GSK
상세 →NCT04162210
3상모집 중단 (진행 중)· Lupus Erythematosus, Systemic
Synergetic B-cell Immunomodulation in SLE - 2nd Study.
협력: GSK
상세 →NCT03747159
3상모집 중단 (진행 중)· Infection, Human Immunodeficiency Virus
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
협력: GSK
상세 →NCT02951052
3상모집 중단 (진행 중)· HIV Infections
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
협력: GSK
상세 →NCT02938520

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.